How much funding has IAMBIC raised?

IAMBIC has raised $1.0M in total funding, most recently a Grant round.

Where is IAMBIC headquartered?

IAMBIC is headquartered in New York, New York, United States.

What industry is IAMBIC in?

IAMBIC operates in Artificial Intelligence.

IAMBIC

Q: Who are IAMBIC's investors?

IAMBIC's investors include National Science Foundation, Techstars.

Better technology for better medicines

New York, United States · Founded 2024 · $1.0M raised

Artificial Intelligence

Headquarters: New York, New York
Employees: 51–200
Founded: 2024
Business Model: B2B

Website: iambic.co
Total Funding: $1.0M
Last Round: $1.0M GrantJan 2024
Rounds: 2

About

Iambic Therapeutics is a clinical-stage AI-driven biotech company headquartered in La Jolla, California. Founded in 2019, Iambic has built a cutting-edge platform combining multimodal transformer AI (Enchant) and co-folding technology (NeuralPLexer) to tackle the most challenging problems in drug discovery. The platform enables high-throughput experimental cycles that convert novel molecular designs into biological insights each week, delivering differentiated clinical candidates years faster than industry standard. Iambic's pipeline includes programs targeting HER2, KIF18A, and CDK2/4 for various cancers. The company has announced strategic collaborations with Takeda and Lundbeck.

Summary

IAMBIC is an Artificial Intelligence company based in New York, United States, founded in 2024. It has raised $1.0M in total across 2 rounds, most recently a $1.0M Grant round in Jan 2024. Investors include National Science Foundation and Techstars.